CLOV vs NVCR · rev $1.37B vs rev $605.2M
Clover Health Investments Corp (CLOV) versus Novocure Ltd (NVCR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Novocure Ltd (NVCR) is a medical devices company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NVCR revenue for 2024-12-31 was $605.2M. Net income was -$168.6M. Revenue was up 18.8% from 2023-12-31 to 2024-12-31. NVCR currently screens at market cap $1.99B.
CLOV currently screens at market cap $1.55B. NVCR currently screens at market cap $1.99B.
Not investment advice. Open the CLOV and NVCR stock pages for the full models.
Not investment advice.